Características clínicas y epidemiológicas de las neoplasias mieloproliferativas philadelphia negativas en el sistema público de salud de Chile.

Autores/as

  • Ximena Valladares Hospital del Salvador
  • Rafael Benavente
  • Christine Rojas Hospital Gustavo Fricke
  • Camila Peña Hospital del Salvador
  • Rodrigo Valenzuela Hospital del Salvador
  • Virginia Monardes HOspital del Salvador
  • Hernán López Hospital Barros Luco
  • Marcelo Abarca Hospital Sótero del Río
  • Pilar León Hospital Van BUren
  • Rocío Osorio Hospital de Arica
  • Erika Pérez
  • Pablo Soto Hospital de Puerto Montt
  • Gabriel La Rocca Hospital de Coyhaique
  • Daniela Cardemil Hospital de Magallanes
  • Vivianne Torres Hospital de Valdivia
  • Marvila Intriago Bermeo Hospital de La Serena
  • María Elena Cabrera Hospital del Salvador
  • María Soledad Undurraga Hospital del Salvador

Palabras clave:

Janus Kinase 2, Polycythemia Vera, Primary Myelofibrosis, Thrombocythemia, Essential

Resumen

Background: Philadelphia-negative Myeloproliferative Neoplasms (Ph-MPN) are chronic hematological disorders characterized by the overproduction of one or more mature myeloid blood cell lineages. Classical Ph-MPN are Polycythemia Vera (PV), Essential Thrombocytopenia (ET) and Primary Myelofibrosis (PMF). Aim: To assess the epidemiological, clinical and diagnostic characteristics of Ph-MPN in Chile. Material and methods: Retrospective review of medical records of all patients referred as MPN from 2012 to 2017. Patients with (9;21) translocation were excluded. Results: Data of 462 cases with a median age of 69 years from 10 public hospitals was reviewed. ET was the most frequently Ph-MNP found. The incidence of Ph-MPN was 1.5 x 100.000 cases. The JAK2 V617F mutation study was performed in 96% of patients and only 30% had a bone marrow biopsy. Thrombotic events were observed in 29% of patients. Bleeding events were observed in 7%. Five-year overall survival was 87%. Conclusions: ET is the most frequent Ph-MPN. The mean incidence was lower than reported in the literature, in part because of a sub diagnosis.

Biografía del autor/a

Ximena Valladares, Hospital del Salvador

Hematóloga

Rafael Benavente

Hematólogo

Christine Rojas, Hospital Gustavo Fricke

Hematóloga

Camila Peña, Hospital del Salvador

Hematóloga

Rodrigo Valenzuela, Hospital del Salvador

Bioquímico

Virginia Monardes, HOspital del Salvador

Bioquímico

Hernán López, Hospital Barros Luco

Hematólogo

Marcelo Abarca, Hospital Sótero del Río

Internista, Residente Hematología Adultos

Pilar León, Hospital Van BUren

Hematóloga

Rocío Osorio, Hospital de Arica

Hematóloga

Erika Pérez

Oncóloga

Pablo Soto, Hospital de Puerto Montt

Hematólogo

Gabriel La Rocca, Hospital de Coyhaique

Hematólogo

Daniela Cardemil, Hospital de Magallanes

Hematóloga

Vivianne Torres, Hospital de Valdivia

Hematóloga

Marvila Intriago Bermeo, Hospital de La Serena

Hematóloga

María Elena Cabrera, Hospital del Salvador

Hematóloga, Profesor titular Universidad de Chile

María Soledad Undurraga, Hospital del Salvador

Hematóloga

Descargas

Publicado

2021-09-08

Cómo citar

Valladares, X., Benavente, R., Rojas, C., Peña, C., Valenzuela, R., Monardes, V., López, H., Abarca, M., León, P., Osorio, R., Pérez, E., Soto, P., La Rocca, G., Cardemil, D., Torres, V., Intriago Bermeo, M., Cabrera, M. E., & Undurraga, M. S. (2021). Características clínicas y epidemiológicas de las neoplasias mieloproliferativas philadelphia negativas en el sistema público de salud de Chile. Revista Médica De Chile, 149(11). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/9408

Número

Sección

Artículos de Investigación

Artículos más leídos del mismo autor/a

1 2 3 4 > >>